[HTML][HTML] The neutrophil-to-lymphocyte ratio: a narrative review
SS Faria, PC Fernandes Jr, MJB Silva… - …, 2016 - ncbi.nlm.nih.gov
Cellular-mediated inflammatory response, lymphocytes, neutrophils, and monocytes are
increasingly being recognised as having an important role in tumorigenesis and …
increasingly being recognised as having an important role in tumorigenesis and …
Routine clinical markers of the magnitude of the systemic inflammatory response after elective operation: a systematic review
Background Operative injury to the body from all procedures causes a stereotypical cascade
of neuroendocrine, cytokine, myeloid, and acute phase responses. This response has been …
of neuroendocrine, cytokine, myeloid, and acute phase responses. This response has been …
[HTML][HTML] Influence of perioperative anaesthetic and analgesic interventions on oncological outcomes: a narrative review
Surgery is an important treatment modality for the majority of solid organ cancers.
Unfortunately, cancer recurrence following surgery of curative intent is common, and …
Unfortunately, cancer recurrence following surgery of curative intent is common, and …
Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis
JL Ethier, D Desautels, A Templeton, PS Shah… - Breast Cancer …, 2017 - Springer
Background The presence of a high neutrophil-to-lymphocyte ratio (NLR) has been
associated with increased mortality in several malignancies. Here, we quantify the effect of …
associated with increased mortality in several malignancies. Here, we quantify the effect of …
Prognostic value of neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio for breast cancer patients: An updated meta‐analysis of 17079 individuals
W Guo, X Lu, Q Liu, T Zhang, P Li, W Qiao… - Cancer …, 2019 - Wiley Online Library
Aims This study aimed to evaluate the prognostic effect of neutrophil‐to‐lymphocyte ratio
(NLR) and platelet‐to‐lymphocyte ratio (PLR) for patients with breast cancer (BC). Methods …
(NLR) and platelet‐to‐lymphocyte ratio (PLR) for patients with breast cancer (BC). Methods …
[HTML][HTML] Repurposing drugs in oncology (ReDO)—Cimetidine as an anti-cancer agent
P Pantziarka, G Bouche, L Meheus… - …, 2014 - ncbi.nlm.nih.gov
Cimetidine, the first H 2 receptor antagonist in widespread clinical use, has anti-cancer
properties that have been elucidated in a broad range of pre-clinical and clinical studies for …
properties that have been elucidated in a broad range of pre-clinical and clinical studies for …
DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m6A-demethylation of FOXM1 and NANOG
Platinum based drugs alone or in combination with 5FU and docetaxel are common regimen
chemotherapeutics for the treatment of advanced OSCC. Chemoresistance is one of the …
chemotherapeutics for the treatment of advanced OSCC. Chemoresistance is one of the …
Neutrophil to lymphocyte ratio as prognostic and predictive factor in breast cancer patients: a systematic review
I Corbeau, W Jacot, S Guiu - Cancers, 2020 - mdpi.com
Inflammatory blood markers (IBM), such as the neutrophil to lymphocyte ratio (NLR), have
emerged as potential prognostic factors in various cancers, including breast cancer (BC) …
emerged as potential prognostic factors in various cancers, including breast cancer (BC) …
Perioperative anesthesia care and tumor progression
MW Sekandarzad, AAJ van Zundert, PB Lirk… - Anesthesia & …, 2017 - journals.lww.com
IMMUNE PATHOGENESIS The principal line of defense against cancer cell invasion and
metastasis is established via the host's innate and adaptive immune response. The key …
metastasis is established via the host's innate and adaptive immune response. The key …
Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics
CW McAleer, CJ Long, D Elbrecht… - Science translational …, 2019 - science.org
A pumpless, reconfigurable, multi-organ–on–a–chip system containing recirculating serum-
free medium can be used to predict preclinical on-target efficacy, metabolic conversion, and …
free medium can be used to predict preclinical on-target efficacy, metabolic conversion, and …